CVTTHi001-A-1

General

Cell Line

hPSCreg name CVTTHi001-A-1
Cite as:
CVTTHi001-A-1
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 24th September 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Centro Vasco de Transfusión y Tejidos Humanos (CVTTH)

External Databases

BioSamples SAMEA115903643

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
APD syndrome type 2 (mutations in the PIK3R1 gene)
Synonyms
  • APDS
  • Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation

External Databases (Donor)

BioSamples SAMEA7274737

Ethics

Also have a look at the ethics information for the parental line CVTTHi001-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line CVTTHi001-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
SSEA-4
Yes
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Genetic modifications
PIK3R1 (target)
Genetic modifications not related to a disease
Gene knock-in
chr 5q13.1
CRISPR-associated (CRISPR/Cas) System